Related Experiment Video

Updated: Jun 6, 2026

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
10:28

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function

Published on: March 15, 2022

Antiplatelet and antithrombotic treatment after primary percutaneous coronary intervention: balancing safety and

Marco Valgimigli1, Monica Minarelli

  • 1University of Ferrara, Italy and Cardiovascular Research Centre, Salvatore Maugeri Foundation, IRCCS Gussago (BS), Italy. vlgmrc@unife.it

American Heart Journal
|December 15, 2010
PubMed

Insights

Antiplatelet therapy reduces vascular events but increases bleeding risk in high-risk patients. Balancing efficacy and safety is crucial for optimal secondary prevention and cardiovascular outcomes.

Area of Science:

  • Cardiology
  • Pharmacology

Background:

  • Antiplatelet therapy is vital for secondary prevention in patients with acute ischemic events and acute coronary syndromes.
  • Long-term use reduces vascular events but elevates bleeding risk, potentially worsening outcomes.

Purpose of the Study:

  • To discuss the critical balance between antiplatelet therapy efficacy and safety.
  • To explore strategies for optimizing antiplatelet treatment in high-risk patients.

Main Methods:

  • Review of current evidence on antiplatelet therapy in secondary prevention.
  • Discussion of agent selection, combination, and dose optimization.
  • Consideration of personalized approaches including genotyping and phenotype assessment.

Main Results:

  • Antiplatelet therapy significantly lowers ischemic event risk.
  • Increased bleeding risk is associated with intensified regimens, potentially leading to discontinuation.
  • A personalized approach is necessary to optimize the risk-benefit ratio.

Conclusions:

  • Achieving an optimal balance between preventing ischemic events and minimizing bleeding is essential.
  • Tailoring antiplatelet therapy based on individual patient factors improves safety and efficacy.
  • Further research and clinical practice should focus on personalized antiplatelet strategies.

Related Concept Videos

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...